Drugs Made In America Acquisition Closes $500 Million IPO

MT Newswires Live
Sep 27, 2025

Drugs Made In America Acquisition (DMIIU) said late Friday it has closed its $500 million initial public offering.

The blank check company's units started trading on Nasdaq on Thursday under the ticker "DMIIU."

Each unit comprises of one ordinary share and one right to receive one-tenth of an ordinary share after the completion of an initial business combination.

After the components of units start trading separately, the ordinary shares and rights are expected to list on Nasdaq under the symbols "DMII" and "DMIIR," respectively.

Underwriters were given a 45-day option to buy another 7.5 million units, the firm added.

Additionally, the company raised $12 million in a private placement of 1.2 million shares, priced at $10 per unit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10